Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ornithine decarboxylase (ODC) is regulated by its metabolic products through a feedback loop that employs a second protein,
antizyme 1
(
AZ1
).
AZ1
accelerates the degradation of ODC by the proteasome. We used purified components to study the structural elements required for proteasomal recognition of this ubiquitin-independent substrate. Our results demonstrate that
AZ1
acts on ODC to enhance the association of ODC with the proteasome, not the rate of its processing. Substrate-linked or free
polyubiquitin
chains compete for
AZ1
-stimulated degradation of ODC. ODC-
AZ1
is therefore recognized by the same element(s) in the proteasome that mediate recognition of
polyubiquitin
chains. The 37 C-terminal amino acids of ODC harbor an
AZ1
-modulated recognition determinant. Within the ODC C terminus, three subsites are functionally distinguishable. The five terminal amino acids (ARINV, residues 457-461) collaborate with residue C441 to constitute one recognition element, and
AZ1
collaborates with additional constituents of the ODC C terminus to generate a second recognition element.
...
PMID:Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. 1266 Jan 56